Josep Comin-Colet Selected Research

Josep Comin-Colet Research Topics

Disease

52	Heart Failure 03/2024 - 01/2013
21	Iron Deficiencies 08/2023 - 01/2013
7	Heart Diseases (Heart Disease) 05/2024 - 01/2018
4	Cardiomyopathies (Cardiomyopathy) 01/2023 - 01/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2015
3	Heart Arrest (Cardiac Arrest) 01/2023 - 01/2021
3	Diabetes Mellitus 10/2022 - 01/2022
3	Atherosclerosis 12/2020 - 01/2018
2	Hyperkalemia 03/2024 - 10/2019
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2024 - 01/2023
2	COVID-19 09/2023 - 12/2020
2	Critical Illness (Critically Ill) 01/2023 - 01/2021
2	Ventricular Tachycardia 01/2023 - 01/2021
2	Sudden Death 01/2023 - 01/2021
2	Atrial Fibrillation 11/2022 - 01/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2020 - 01/2019
2	Inflammation (Inflammations) 12/2020 - 11/2018
2	Anemia 10/2020 - 01/2017
2	Pulmonary Hypertension 03/2020 - 01/2020
2	Takotsubo Cardiomyopathy 03/2020 - 01/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2020 - 01/2020
2	Cardiogenic Shock 03/2020 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2020
2	Stroke (Strokes) 11/2018 - 10/2013
1	Hyperplasia 10/2022
1	Acute Coronary Syndrome 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Angioedema 10/2019

Drug/Important Bio-Agent (IBA)

15	IronIBA 08/2023 - 10/2013
13	ferric carboxymaltoseIBA 01/2023 - 01/2013
9	dapagliflozinIBA 03/2024 - 01/2022
8	Transferrin (beta 2 Transferrin)IBA 12/2020 - 04/2013
8	Ferritins (Ferritin)IBA 12/2020 - 04/2013
6	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2022 - 09/2017
6	Simendan (Levosimendan)IBA 03/2020 - 09/2017
5	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2018
4	Natriuretic PeptidesIBA 05/2024 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 08/2023 - 09/2018
3	Transferrin Receptors (Transferrin Receptor)IBA 08/2023 - 01/2019
3	AngiotensinsIBA 01/2022 - 10/2019
3	Valsartan (Vals)FDA Link 01/2020 - 01/2018
3	Neprilysin (Neutral Endopeptidase)IBA 01/2020 - 01/2018
3	CalciumIBA 12/2019 - 09/2018
2	empagliflozinIBA 10/2023 - 01/2022
2	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 11/2017
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2022
2	Clopidogrel (Plavix)FDA Link 01/2022 - 12/2020
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2022
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2014
2	Complement System Proteins (Complement)IBA 12/2021 - 12/2018
2	Enalapril FDA LinkGeneric 01/2021 - 01/2020
2	paragonIBA 01/2020 - 01/2018
2	CatecholaminesIBA 12/2019 - 01/2019
2	DiureticsIBA 12/2019 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2019 - 01/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2019 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 01/2018
2	C-Reactive ProteinIBA 11/2018 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 01/2018 - 11/2017
2	Prostaglandins AIBA 05/2016 - 03/2015
1	finerenoneIBA 05/2024
1	PotassiumIBA 03/2024
1	SaltsIBA 02/2024
1	CarbohydratesIBA 02/2023
1	GadoliniumIBA 01/2023
1	Everolimus FDA Link 10/2022
1	zotarolimusIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	ReninIBA 01/2022
1	AldosteroneIBA 01/2022
1	SugarsIBA 01/2022
1	SodiumIBA 01/2022
1	TicagrelorIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Chemokine CX3CL1IBA 12/2020
1	ChemokinesIBA 12/2020
1	tocilizumab (atlizumab)FDA Link 12/2020
1	Saccharated Ferric Oxide (Venofer)FDA Link 01/2020
1	Dobutamine FDA LinkGeneric 12/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2019
1	Dopamine (Intropin)FDA LinkGeneric 12/2019
1	Vasodilator Agents (Vasodilators)IBA 12/2019
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 12/2019
1	Milrinone (Primacor)FDA LinkGeneric 12/2019
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 12/2019
1	UlaritideIBA 11/2019
1	sacubitrilIBA 10/2019

Therapy/Procedure

16	Therapeutics 01/2023 - 01/2013
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2021
2	Stents 10/2022 - 01/2022
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 01/2021
2	Critical Care (Surgical Intensive Care) 03/2020 - 01/2020
1	Drug Tapering 03/2024
1	Heart-Assist Devices 01/2023
1	Defibrillators (Defibrillator) 01/2023
1	Long-Term Care 01/2022
1	Drug-Eluting Stents 01/2022